Panbela Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.30-$19
Market Cap
$1.6M
Shares Short
106,974

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$34.51

News

See more

Yahoo Finance • last year

Panbela Announces 2nd Independent Safety Review of the ASPIRE Registration Clinical Trial: Recommended Continuation with no Trial Modification

Yahoo Finance • last year

Panbela Provides Business Update and Reports Q3 2023 Financial Results

Yahoo Finance • last year

Panbela Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds Priced At-the-Market

Yahoo Finance • last year

Panbela Announces Publication of Preclinical and Clinical Data Titled: Inhibition of Polyamine Biosynthesis Preserves β Cell Function in Type 1 Diabetes

About

CEO
Dr. Jennifer K. Simpson CRNP, M.S.N., Ph.D.
CFO
Ms. Susan Horvath
Address
712 Vista Boulevard, Waconia, MN, United States, 55387
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
7